These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31533096)

  • 41. Oral versus intravenous iron supplementation in peritoneal dialysis patients.
    Johnson DW; Herzig KA; Gissane R; Campbell SB; Hawley CM; Isbel NM
    Perit Dial Int; 2001; 21 Suppl 3():S231-5. PubMed ID: 11887827
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anaemia of prematurity: treatment with erythropoietin.
    Carbonell-Estrany X; Figueras-Aloy J
    Early Hum Dev; 2001 Nov; 65 Suppl():S63-7. PubMed ID: 11755036
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Iron chelation therapy and its influence on the alleviation of EPO resistance in MDS patients].
    Zhang Y; Xiao C; Gu SC; Chang CK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1027-32. PubMed ID: 25130822
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recombinant human erythropoietin for the treatment of anemia in the myelodysplastic syndromes: a clinical and erythrokinetic assessment.
    Verhoef GE; Zachée P; Ferrant A; Demuynck H; Selleslag D; Van Hove L; Deckers F; Boogaerts MA
    Ann Hematol; 1992 Jan; 64(1):16-21. PubMed ID: 1739754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recombinant human erythropoietin in patients with myelodysplastic syndrome and myelofibrosis.
    Mohr B; Herrmann R; Huhn D
    Acta Haematol; 1993; 90(2):65-70. PubMed ID: 8285020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recombinant human granulocyte-macrophage colony-stimulating factor plus recombinant human erythropoietin may improve anemia in selected patients with myelodysplastic syndromes.
    Hansen PB; Johnsen HE; Hippe E; Hellström-Lindberg E; Ralfkiaer E
    Am J Hematol; 1993 Dec; 44(4):229-36. PubMed ID: 8237992
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recombinant human erythropoietin in patients with inflammatory bowel disease and refractory anemia: a 15-year single center experience.
    Katsanos KH; Tatsioni A; Natsi D; Sigounas D; Christodoulou DK; Tsianos EV
    J Crohns Colitis; 2012 Feb; 6(1):56-61. PubMed ID: 22261528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients.
    Kalantar-Zadeh K; McAllister CJ; Lehn RS; Lee GH; Nissenson AR; Kopple JD
    Am J Kidney Dis; 2003 Oct; 42(4):761-73. PubMed ID: 14520627
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term follow-up of myelodysplastic syndrome patients with moderate/severe anaemia receiving human recombinant erythropoietin + 13-cis-retinoic acid and dihydroxylated vitamin D3: independent positive impact of erythroid response on survival.
    Crisà E; Foli C; Passera R; Darbesio A; Garvey KB; Boccadoro M; Ferrero D
    Br J Haematol; 2012 Jul; 158(1):99-107. PubMed ID: 22571649
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Response to oral sucrosomial iron supplementation in patients undergoing bariatric surgery. The BARI-FER study.
    Ciudin A; Simó-Servat O; Balibrea JM; Vilallonga R; Hernandez C; Simó R; Mesa J
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Jan; 65(1):17-20. PubMed ID: 29233512
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Erythropoietin administration is associated with improved T-cell properties in patients with myelodysplastic syndromes.
    Deshet-Unger N; Oster HS; Prutchi-Sagiv S; Maaravi N; Golishevski N; Neumann D; Mittelman M
    Leuk Res; 2017 Jan; 52():20-27. PubMed ID: 27870945
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients.
    Follo MY; Mongiorgi S; Clissa C; Paolini S; Martinelli G; Martelli AM; Fioravanti G; Manzoli L; Finelli C; Cocco L
    Leukemia; 2012 Dec; 26(12):2474-82. PubMed ID: 22596089
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy.
    Henry DH; Dahl NV; Auerbach M; Tchekmedyian S; Laufman LR
    Oncologist; 2007 Feb; 12(2):231-42. PubMed ID: 17296819
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Erythropoietin plus granulocyte colony-stimulating factor in the treatment of myelodysplastic syndromes. Identification of a subgroup of responders. The Spanish Erythropathology Group.
    Remacha AF; Arrizabalaga B; Villegas A; Manteiga R; Calvo T; Julià A; Fernández Fuertes I; González FA; Font L; Juncà J; del Arco A; Malcorra JJ; Equiza EP; de Mendiguren BP; Romero M
    Haematologica; 1999 Dec; 84(12):1058-64. PubMed ID: 10586205
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anaemia.
    Ponchio L; Beguin Y; Farina G; Pedrazzoli P; Pedrotti C; Poggi G; Rosti V; Bergamaschi G; Battistel V; Cazzola M
    Haematologica; 1992; 77(6):494-501. PubMed ID: 1289186
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: a randomized, double-blind, placebo-controlled study.
    Ohls RK; Harcum J; Schibler KR; Christensen RD
    J Pediatr; 1997 Nov; 131(5):661-5. PubMed ID: 9403642
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients.
    Goicoechea M; Vazquez MI; Ruiz MA; Gomez-Campdera F; Perez-García R; Valderrábano F
    Nephron; 1998; 78(1):23-7. PubMed ID: 9453399
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.
    Wilson J; Yao GL; Raftery J; Bohlius J; Brunskill S; Sandercock J; Bayliss S; Moss P; Stanworth S; Hyde C
    Health Technol Assess; 2007 Apr; 11(13):1-202, iii-iv. PubMed ID: 17408534
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral iron supplementation in preterm infants treated with erythropoietin.
    Fujiu T; Maruyama K; Koizumi T
    Pediatr Int; 2004 Dec; 46(6):635-9. PubMed ID: 15660859
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomized trial of sucrosomial iron supplementation in patients with chemotherapy-related anemia treated with ESA.
    Zuccarini A; Cicognini D; Tancredi R; Ferrari A; Rizzo G; Lasagna A; Caccialanza R; Cavanna L; Orlandi E; Biasini C; Molinaro P; Garigliano D; Costantino A; Moroni M; Perrone L; Alessio NL; Rovati B; Ferretti VV; Klersy C; Pedrazzoli P
    Support Care Cancer; 2022 Sep; 30(9):7645-7653. PubMed ID: 35678882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.